title: Decreased toxicity with 2 weeks on and 1 week off schedule of sunitinib in metastatic renal cell carcinoma: is it a mirage or an oasis?
authors.affiliation: Institute for Drug Development, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: Malikl@uthscsa.edu.
authors.forename: Laeeq
authors.initials: L
authors.lastname: Malik
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D007211:Indoles; D011758:Pyrroles